Skin Laboratory PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	191.6	229.13	271.8	282.12	197.55	168.48
Other Revenue	2.42	1.4	0.99	0.58	1.03	0.09
Revenue	194.03	230.53	272.8	282.7	198.57	168.57
Revenue Growth (YoY)	-18.97%	-15.49%	-3.50%	42.37%	17.80%	-
Cost of Revenue	52.46	57.5	63.23	70.65	65.56	54.19
Gross Profit	141.56	173.03	209.56	212.05	133.02	114.37
Selling, General & Admin	120.52	159.5	188.28	196.86	96.43	76.26
Operating Expenses	120.52	159.5	188.28	196.86	96.43	76.26
Operating Income	21.04	13.53	21.28	15.19	36.59	38.11
Interest Expense	-0.17	-0.25	-0.19	-0.18	-0.18	-0.08
EBT Excluding Unusual Items	20.87	13.28	21.1	15.01	36.41	38.03
Gain (Loss) on Sale of Investments	0.01	0.25	-0.07	-	-	-
Pretax Income	20.88	13.53	21.02	15.01	36.41	38.03
Income Tax Expense	4.24	2.86	4.24	3.15	7.64	9.29
Net Income	16.64	10.67	16.79	11.86	28.77	28.75
Net Income to Common	16.64	10.67	16.79	11.86	28.77	28.75
Net Income Growth	209.17%	-36.44%	41.59%	-58.80%	0.10%	-
Shares Outstanding (Basic)	102	43	2	2	2	-
Shares Outstanding (Diluted)	102	43	2	2	2	-
Shares Change (YoY)	51.80%	2048.36%	-	-	-	-
EPS (Basic)	0.16	0.25	8.39	5.93	14.39	-
EPS (Diluted)	0.16	0.25	8.39	5.93	14.39	-
EPS Growth	103.66%	-97.04%	41.59%	-58.80%	-	-
Free Cash Flow	21.1	3.8	26.25	4.62	10.87	8.64
Free Cash Flow Per Share	0.21	0.09	13.12	2.31	5.43	-
Dividend Per Share	27.665	27.580	7.500	8.000	6.830	6.750
Dividend Growth	268.87%	267.73%	-6.25%	17.13%	1.19%	-
Gross Margin	72.96%	75.06%	76.82%	75.01%	66.98%	67.85%
Operating Margin	10.85%	5.87%	7.80%	5.37%	18.42%	22.61%
Profit Margin	8.58%	4.63%	6.15%	4.19%	14.49%	17.05%
Free Cash Flow Margin	10.87%	1.65%	9.62%	1.63%	5.47%	5.13%
EBITDA	21.16	14.46	21.63	15.61	37.03	38.4
EBITDA Margin	10.91%	6.27%	7.93%	5.52%	18.65%	22.78%
D&A For EBITDA	0.11	0.92	0.35	0.42	0.44	0.29
EBIT	21.04	13.53	21.28	15.19	36.59	38.11
EBIT Margin	10.85%	5.87%	7.80%	5.37%	18.42%	22.61%
Effective Tax Rate	20.31%	21.16%	20.16%	20.99%	20.97%	24.42%
Revenue as Reported	194.03	230.53	272.8	282.7	198.57	168.57
Advertising Expenses	-	121.33	150.16	-	48.6	33.61

Source: S&P Global Market Intelligence. Standard template. Financial Sources.